Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
Woon H. Chong, Biplab K. Saha, Ananthakrishnan Ramani, et al.
Infection (2021) Vol. 49, Iss. 4, pp. 591-605
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
Kamalesh Kumar Patel, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 9, pp. 2349-2359
Open Access | Times Cited: 421
Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review
Woon H. Chong, Kristoffer Neu
Journal of Hospital Infection (2021) Vol. 113, pp. 115-129
Open Access | Times Cited: 122
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis
Woon H. Chong, Biplab K. Saha, Kristoffer Neu
Infection (2021) Vol. 50, Iss. 1, pp. 43-56
Open Access | Times Cited: 68
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression
Bradley J. Langford, Miranda So, Valerie Leung, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 491-501
Open Access | Times Cited: 68
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
Ruben Mylvaganam, Joseph I. Bailey, Jacob I. Sznajder, et al.
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210194-210194
Open Access | Times Cited: 68
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms
Viviani Mendes de Almeida, Daiane F. Engel, Mayra Fernanda Ricci, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 33
Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome
Alessandra Iacovelli, Alessandra Oliva, Guido Siccardi, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data
Xinyi Yang, Xiying Li, Shengyue Qiu, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106183-106183
Closed Access | Times Cited: 9
Use of Antimicrobials among Suspected COVID-19 Patients at Selected Hospitals, Bangladesh: Findings from the First Wave of COVID-19 Pandemic
Syeda Mah‐E‐Muneer, Md Zakiul Hassan, Md Abdullah Al Jubayer Biswas, et al.
Antibiotics (2021) Vol. 10, Iss. 6, pp. 738-738
Open Access | Times Cited: 43
Immunometabolic signatures predict risk of progression to sepsis in COVID-19
Ana Sofía Herrera-Van Oostdam, Julio Enrique Castañeda‐Delgado, Juan José Oropeza-Valdez, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0256784-e0256784
Open Access | Times Cited: 40
Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials
Citlaly Gutiérrez-Rodelo, Rafael A. Salinas, Erika Armenta-Jaime, et al.
Coordination Chemistry Reviews (2022) Vol. 457, pp. 214402-214402
Open Access | Times Cited: 36
Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and Clinical Outcomes: Understanding of the Recent Three Years’ Trends
Taghreed A. Hafiz, Esraa Aldawood, Alaa Albloshi, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2506-2506
Open Access | Times Cited: 29
PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens
Chad W. Euler, Assaf Raz, Anaise Hernandez, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 5
Open Access | Times Cited: 20
Effects of COVID-19 and pneumococcal conjugate vaccines on hospitalized older COVID-19 patients in Türkiye
Güzin Zeren Öztürk, İlknur Demir, Zeynep U. Yılmaz
Eastern Mediterranean Health Journal (2025) Vol. 31, Iss. 1, pp. 29-34
Open Access
Effects of COVID-19 and pneumococcal conjugate vaccines on hospitalized older COVID-19 patients in Türkiye
Güzin Zeren Öztürk, İlknur Demir, Zeynep U. Yılmaz
Eastern Mediterranean Health Journal (2025) Vol. 31, Iss. 1, pp. 24-29
Open Access
Microbiological findings in a cohort of patients with coronavirus disease 2019 and venovenous extracorporeal membrane oxygenation
Christian Glück, Eugen Widmeier, Sven Maier, et al.
Medizinische Klinik - Intensivmedizin und Notfallmedizin (2025)
Open Access
Diagnostic Value of 99mTc-Ubiquicidin Scintigraphy in Differentiating Bacterial from Nonbacterial Pneumonia
Sepideh Khoshbakht, Soudabeh Zare, Mahdi Khatuni, et al.
Cancer Biotherapy and Radiopharmaceuticals (2025)
Closed Access
Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy
Maurizio Gabrielli, Laura Franza, Alessandra Esperide, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 192-192
Open Access | Times Cited: 24
High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: A single centre retrospective cohort study
Guiliana Mas, Pedro J. Ortiz, Jorge Huaringa-Marcelo, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0265089-e0265089
Open Access | Times Cited: 24
Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outcome
Maria Antonia De Francesco, Liana Signorini, Simone Piva, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 14
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial
Justin Z. Chen, Holly Hoang, Maryna Yaskina, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 6, pp. 673-682
Open Access | Times Cited: 13
Leading Pathogens Involved in Co-Infection and Super-Infection with COVID-19: Forensic Medicine Considerations after a Systematic Review and Meta-Analysis
Roberto Scendoni, Emanuele Bury, Isabella Lima Arrais Ribeiro, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 646-646
Open Access | Times Cited: 12
Coronavirus Disease 2019: Clinics, Treatment, and Prevention
Francesco Burkert, Lukas Lanser, Rosa Bellmann‐Weiler, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 28
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.
Elisa Viciani, Paolo Gaibani, Andrea Castagnetti, et al.
International Journal of Infectious Diseases (2022) Vol. 117, pp. 233-240
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top